Vaxcyte Announces Separate $500M Offerings for Equity/Pre-Funded Warrants and Convertible Notes
Vaxcyte (NASDAQ: PCVX) has announced two separate public offerings totaling $1 billion. The first offering includes up to $500 million in common stock and pre-funded warrants, while the second involves issuing $500 million aggregate principal amount of convertible senior notes due 2032. The company plans to grant underwriters a 30-day option for additional shares or notes. These offerings are intended to provide capital that can be used for general corporate purposes and other strategic initiatives, though specific uses have not been detailed at this time.
Tickers: $PCVX